chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Nerve injury, Pain, Vaccination failure
Clinical narrative: Suspected vaccination failure; Got a really bad case of shingles; Residual nerve damage; Painful symptoms; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Got a really bad case of shingles), nerve damage (Verbatim: Residual nerve damage) and pain (Verbatim: Painful symptoms). The patient was treated with medication unknown (Pill (Medication Unknown)). The outcome of the vaccination failure was unknown and the outcome of the shingles, nerve damage and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, nerve damage and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, nerve damage and pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-March-2023 This case was reported by a patient via interactive digital media. The reporter's one of closest friends received the shingles vaccine. The patient got a really bad case of shingles regardless.  The patient really think that the physician killed with all the other pills and medications they gave him to treat all the residual nerve damage and painful symptoms. The follow up would not possible, as no contact, details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: I had the shingle shot still got them/Suspected Vaccination Failure; I had shingles about 2 weeks ago.; painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In NOV-2022, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I had the shingle shot still got them/Suspected Vaccination Failure) (serious criteria GSK medically significant), shingles (Verbatim: I had shingles about 2 weeks ago.) and pain (Verbatim: painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-MAR-2023 The case was received from the patient via interactive digital media.  The patient stated he or she had shingles about two weeks ago. The patient had the shot too but still got them. Shingles were very painful. The follow-up could not be possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: I do that and I still got it/Suspected vaccination failure; still got it; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I do that and I still got it/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: still got it). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 The case was received from the patient via interactive digital media. The patient got the shot and still got them. The follow-up could not be possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got shingles again/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had it for 3.5 months).   On an unknown date, the patient received Shingles vaccine. In DEC-2022, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got shingles again/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by patient via interactive digital media. The physician said get vaccine and the patient did. It cost 400 dollars to the patient. The patient got shingles again last week.  The patient stated that waste of money. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow up was not possible, as no contact details were available.
Sex: F
Vaccine: COVID19, FLUX, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; Shingles very mild case; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis and COVID-19 VACCINE (COVID VACCINE) for prophylaxis.   Family history included shingles (patient's sister got shingles).   On an unknown date, the patient received Shingles vaccine, Flu vaccine and COVID VACCINE. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles very mild case). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The reporter considered the shingles to be unrelated to Flu vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the shingles to be unrelated to Flu vaccine.   Additional Information: GSK receipt date: 31-MAR-2023 This case was reported by consumer via (Instagram) interactive digital media. The patient's sister never got the flu shot nor the covid vaccines and got shingles, they hurt her and lasted quite a bit. However, covid was not a thing yet. The patient had a very mild case and did get the vaccines for both. The reporter did not think to link flu vaccine to shingles. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. It was unknown if the reporter considered the shingles to be related to covid vaccine. Follow up was not possible, as no contact details were available. This case is linked with US2023AMR067413 and US2023AMR067429, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR067413:Same reporter US-GSK-US2023AMR067429:Same reporter
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, Impaired work ability, Pain
Clinical narrative: Patient received a 3rd shot of Shingrix.   Patient was feeling pain and fatigue the following day 5/5/23.  Had to stay home from work.
Age: 11.0
Sex: M
Vaccine: COVID19-2, FLU4, MNQ, TDAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: The Pfizer bivalent vaccine which was given on 3/20/23 had a before use date of 12/22/22. No symptoms were shown.
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test normal, COVID-19, Cough, Fatigue, SARS-CoV-2 test positive
Clinical narrative: I experienced greater fatigue and a slight cough at first.  Tested on 4/18/2023 with an At Home COVID-19 test, positive.  4/19 doctors office referred to an Urgent Care that specialized in COVID-19 cases.  The Physician?s assistant there had a blood test before proscribing Paxlovid and to treat symptomatically.  Barely noticed any symptoms and by the end of the 4th day taking Paxlovid, symptoms were not noticeable.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, Body temperature increased, Cough
Clinical narrative: On 5/6/2023 at about 7 PM, I became incredibly weak, and my sinuses were blocked. On the morning of 5/7/2023, I woke up and continued to be very tired and had a temperature of 101.9. I then took two home antigen tests and got a positive result on both of them. Later that night, I developed a dry cough. That night, I got very limited sleep. On the morning of 5/10/2023, I called my doctor, who prescribed me prednisone, a Z-Pak, loratadine, and an albuterol inhaler to use in case of chest tightness and breathing issues. I have not had to use the inhaler. I asked for Paxlovid, but for some reason, he refused to prescribe it to me. On 5/9/2023 and 5/10/2023, I saw no improvement, but I did see improvement on 5/11/2023. I experienced no coughing, no fever, and reduced sinus congestion. As of now, my sinuses are almost clear, and I have regained about 85% of my normal energy level. I continue to have no coughing and no fever. I lost my senses of taste and smell on 5/8/2023, but they are now improving.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Laboratory test abnormal, Sinonasal obstruction, Sinus congestion
Clinical narrative: On 5/6/2023 at about 7 PM, I became incredibly weak, and my sinuses were blocked. On the morning of 5/7/2023, I woke up and continued to be very tired and had a temperature of 101.9. I then took two home antigen tests and got a positive result on both of them. Later that night, I developed a dry cough. That night, I got very limited sleep. On the morning of 5/10/2023, I called my doctor, who prescribed me prednisone, a Z-Pak, loratadine, and an albuterol inhaler to use in case of chest tightness and breathing issues. I have not had to use the inhaler. I asked for Paxlovid, but for some reason, he refused to prescribe it to me. On 5/9/2023 and 5/10/2023, I saw no improvement, but I did see improvement on 5/11/2023. I experienced no coughing, no fever, and reduced sinus congestion. As of now, my sinuses are almost clear, and I have regained about 85% of my normal energy level. I continue to have no coughing and no fever. I lost my senses of taste and smell on 5/8/2023, but they are now improving.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blindness unilateral, Cerebral artery embolism, Cerebral infarction, Ischaemic cerebral infarction, Ischaemic stroke
Clinical narrative: Cerebral infarction, unspecified mechanism (163.9).  Ischemic Stroke:  patient without risk factors, new Left CRAO (Central Retinal Arterial Occlusion) and also small R superior parietal punctate ischemic infarct on MR, c/f central embolic process, rapid stroke f/u from ED.  Loss of vision in left eye.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Magnetic resonance imaging head abnormal, Retinal artery occlusion
Clinical narrative: Cerebral infarction, unspecified mechanism (163.9).  Ischemic Stroke:  patient without risk factors, new Left CRAO (Central Retinal Arterial Occlusion) and also small R superior parietal punctate ischemic infarct on MR, c/f central embolic process, rapid stroke f/u from ED.  Loss of vision in left eye.
Age: 50.0
Sex: M
Vaccine: HEP, TDAP, VARZOS
Symptoms: Blood pressure increased, Headache
Clinical narrative: Patient said the 3 imz he got yesterday gave him HighBloodPressure. Turns out he didn't take his bp med yesterday and then he woke with a headache this morning. Says he knows his bp is high when he has a HA so then he takes a bp pill. At one point he said he takes bp pill when he has HA and later he said he takes everyday. Not really clear but he didn't take it yesterday. Said his bp was elevated this morning. He took it again and it was still elevated but not as much. About an hour ago he decided to take a 2nd bp pill. HA and elevated bp/pulse were his only complaints. We advised him to sit for a bit (because he was currently on the clock and busy working) and then take bp again. I advised him to see his dr, urgentcare, or hospital if bp does not come down. He sat for a bit but then left.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: Patient is having swelling  in his left elbow, 2 weeks after getting the vaccine. He thinks the swelling is related to the vaccine and wanted it reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Magnetic resonance imaging, Myalgia, Nerve compression, Pain
Clinical narrative: a female patient. I have received all 4 doses of Moderna vaccine on the following dates: January 8, 2021 (Lot: 025620A), February 2, 2021 (Lot: 012M0A), November 6, 2021 (Lot: 037F21A), and May 18, 2022 (Lot: 056A22A). I am writing to Moderna to bring to your attention a potential problem with the side effects of your Covid-19 vaccine. The issue I want to raise is related to a possible side effect of the vaccine that I am personally experiencing.  After the first dose, I developed a burning pain in the back of my thighs, especially on the left side, which gradually also presented on the right. After multiple electromyogram studies, lumbar myelogram test, magnetic resonance imaging, and tomographies, various neurosurgeons issued similar diagnoses of spondylolisthesis conditions and incipient nerve compression. However, the doctors agree that the exams reveal that the conditions visualized in the spine, which typically cause pain in the lower back due to nerve compression problems in the column, are not the ones I currently present with pain in the back of my thighs. And they agree that neurosurgery would not eliminate the symptoms I have been experiencing since 2021. To this day, I still do not know the cause of my symptoms and leg pains. Given this situation, I would like to consult with you at Moderna if you have had any reports from anyone who has reported any side effects of the vaccine, similar to what I am experiencing with muscle pains in the back of my thighs. In case someone has reported similar symptoms, I would like to know if you have identified those symptoms as side effects caused by the Moderna vaccine. If that is the case, I would like to know if you have identified and applied any solution to this problem. I would also appreciate it if you could investigate this matter further and take necessary actions to address any potential risks associated with the side effects of your vaccine. Thank you in advance for your kind attention to this matter and your prompt response.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Spinal myelogram abnormal, Spondylolisthesis
Clinical narrative: a female patient. I have received all 4 doses of Moderna vaccine on the following dates: January 8, 2021 (Lot: 025620A), February 2, 2021 (Lot: 012M0A), November 6, 2021 (Lot: 037F21A), and May 18, 2022 (Lot: 056A22A). I am writing to Moderna to bring to your attention a potential problem with the side effects of your Covid-19 vaccine. The issue I want to raise is related to a possible side effect of the vaccine that I am personally experiencing.  After the first dose, I developed a burning pain in the back of my thighs, especially on the left side, which gradually also presented on the right. After multiple electromyogram studies, lumbar myelogram test, magnetic resonance imaging, and tomographies, various neurosurgeons issued similar diagnoses of spondylolisthesis conditions and incipient nerve compression. However, the doctors agree that the exams reveal that the conditions visualized in the spine, which typically cause pain in the lower back due to nerve compression problems in the column, are not the ones I currently present with pain in the back of my thighs. And they agree that neurosurgery would not eliminate the symptoms I have been experiencing since 2021. To this day, I still do not know the cause of my symptoms and leg pains. Given this situation, I would like to consult with you at Moderna if you have had any reports from anyone who has reported any side effects of the vaccine, similar to what I am experiencing with muscle pains in the back of my thighs. In case someone has reported similar symptoms, I would like to know if you have identified those symptoms as side effects caused by the Moderna vaccine. If that is the case, I would like to know if you have identified and applied any solution to this problem. I would also appreciate it if you could investigate this matter further and take necessary actions to address any potential risks associated with the side effects of your vaccine. Thank you in advance for your kind attention to this matter and your prompt response.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Patient had diagnosis of chicken pox at emergency room on 2/5/2022. Varicella vaccine not needed.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood magnesium normal, Chest X-ray normal, Electrocardiogram normal, Full blood count normal, Syncope
Clinical narrative: Syncopal event while sitting eating dinner lasting 30 seconds, recovered spontaneously
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Troponin normal
Clinical narrative: Syncopal event while sitting eating dinner lasting 30 seconds, recovered spontaneously
Age: 2.5
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/2023 despite beyond use date of 1/22/23
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per immunization system. We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patietna at the time of the vaccination and no adverse reaction reported since given vaccine.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per immunization system. We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patietna at the time of the vaccination and no adverse reaction reported since given vaccine.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per immunization system. We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patietna at the time of the vaccination and no adverse reaction reported since given vaccine.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per immunization system. We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patietna at the time of the vaccination and no adverse reaction reported since given vaccine.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per immunization system. We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patietna at the time of the vaccination and no adverse reaction reported since given vaccine.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per immunization system. We contacted Pfizer for expiration dates, pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patient at the time of the vaccination. No adverse reaction reported since the administration of vaccine.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per immunization system. We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patietna at the time of the vaccination and no adverse reaction reported since given vaccine.
Age: 2.5
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/2023 despite beyond use date of 1/22/23
Age: 1.17
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per Agency. We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised expiration dates and deemed vaccine viable at the time of vaccine administration.  Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to attain expiration dates directly from them.  No adverse reaction reported from the patients at the time of the vaccination and no adverse reaction reported since given vaccine.
Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 1.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/2023 despite beyond use date of 1/22/23
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administration error
Clinical narrative: Reporting administration error.  We contacted Pfizer for expiration dates, pfizer vaccine specialist advised expiration dates and deemed vaccines viable at the time of vaccine administration.  Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted pfizer to attain expirations dates directly from them.    No adverse reaction reported from the patient at the time of vaccination and no adverse reaction  reported since given the vaccine.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per Agency  We contacted Pfizer for expiration dates, pfizer vaccine specialist advised that the expiration dates are deemed viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted pfizer to obtain expirations dates directly from them.  No adverse reaction reported from the patient at the time of vaccination. No adverse reaction reported since the vaccination.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administration error
Clinical narrative: Reporting administration error.   We contacted Pfizer for expiration dates, pfizer vaccine specialist advised that the expiration dates are deemed viable at the time of vaccine administration.  Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted pfizer to obtain expirations dates directly from them.   No adverse reaction reported from the patient at the time of vaccination.  No adverse reaction reported since the administration of vaccination.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product expiration date issue
Clinical narrative: Reporting administration error.  We contacted Pfizer for expiration dates, pfizer vaccine specialist advised expiration dates and deemed vaccine viable t the time of vaccine administration.  Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted pfizer to attain expirations dates directly from them.   No adverse reaction reported from the patient at the time of vaccination and no adverse reaction  reported since given the vaccine.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administration error
Clinical narrative: Reporting administration error.  We contacted Pfizer for expiration dates, pfizer vaccine specialist advised expiration dates and deemed vaccines viable at the time of vaccine administration.  Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted pfizer to attain expirations dates directly from them.    No adverse reaction reported from the patient at the time of vaccination and no adverse reaction  reported since given the vaccine.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per Agency.  We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised that the expiration dates were deemed viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted Pfizer to obtained expiration dates directly from them.  No adverse reactions were reported from the patient at the time of vaccination. No adverse reactions were reported since the administration of vaccination.
Age: 1.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216k22A was  viable until 2/21/23 despite beyond use date of 1/22/23
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product expiration date issue
Clinical narrative: Reporting administration error.   We contacted Pfizer for expiration dates, pfizer vaccine specialist advised that the expiration dates are deemed viable at the time of vaccine administration.  Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted  pfizer to obtain expirations dates directly from them.   No adverse reactions reported from the patient at the time of the vaccination.  No adverse reaction reported since the administration of vaccination.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product expiration date issue
Clinical narrative: Reporting administration error as per Facility.  We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised that the expiration dates were deemed viable at the time of vaccine administration. Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted Pfizer to obtained expiration dates directly from them.  No adverse reactions were reported from the patient at the time of vaccination. No adverse reactions were reported since the administration of vaccination.
Age: 1.67
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product use issue
Clinical narrative: no adverse event, moderna  confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product expiration date issue
Clinical narrative: Reporting administration error per Agency.  We contacted Pfizer for expiration dates, pfizer vaccine specialist advised that the expiration dates are  deemed viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted pfizer to attain expiration dates directly from them.   No adverse reaction reported from the patient at the time of vaccination. No adverse reaction reported since the administration of vaccination.
Age: 1.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/23/23 despite beyond use date of 1/22/23
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product expiration date issue
Clinical narrative: Reporting administration error per Agency. We contacted Pfizer for expiration dates, pfizer vaccine specialist advised expiration dates and deemed vaccines viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted pfizer to attain expiration dates directly from them.   No adverse reaction reported from the patient at the time of vaccination and no adverse reaction reported since given the vaccine.
Age: 1.5
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/23/23 despite beyond use date of 1/22/23
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/23/23 despite beyond use date of 1/22/23
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product expiration date issue
Clinical narrative: Reporting administration error as per Agency.  We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised that the expiration dates were deemed viable at the time of vaccine administration. Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted Pfizer to obtained expiration dates directly from them.  No adverse reactions were reported from the patient at the time of vaccination. No adverse reactions were reported since the administration of vaccination.
Age: 1.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per Agency.  We contacted Pfizer for expiration dates, Pfizer vaccine specialist advised that the expiration dates were deemed viable at the time of vaccine administration. Pfizer vaccine vials only include manufacturer dates on the box and vials. Therefore, we contacted Pfizer to obtained expiration dates directly from them.  No adverse reactions were reported from the patient at the time of vaccination. No adverse reactions were reported since the administration of vaccination
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product use issue
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 2.5
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 1.25
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product use issue
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Reporting administration error as per Agency.  We contacted Pfizer for expiration dates, pfizer vaccine specialist advised that the expiration dates are deemed viable at the time of vaccine administration. Pfizer vaccine vials only include manufactuarer dates on the box and vials. Therefore, we contacted pfizer to obtain expirations dates directly from them.  No adverse reaction reported from the patient at the time of vaccination. No adverse reaction reported since the administration of vaccination.
Age: 1.25
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Bell's palsy, Cellulitis
Clinical narrative: L SIDED BELLS PALSY, ONSET <24 HOURS AFTER VACCINE -           -prednisone, valacyclovir, doxycycline CELLULITIS
Age: 1.25
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Altered state of consciousness, Hyporesponsive to stimuli, Musculoskeletal stiffness, Unresponsive to stimuli
Clinical narrative: 5 min change in consciousness (unresponsive) with stiffening body then 1-2 hours of less responsiveness afterward.
Age: 1.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna  confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product use issue
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/3
Age: 1.92
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 2.33
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 2.5
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was  viable until 2/21/23 despite beyond use date of 1/22/23
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna  confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 0.83
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was  viable until 2/21/23 despite beyond use date of 1/22/23
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 0.75
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23.
Age: 2.33
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 2.75
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 1.25
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 2.58
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna  confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, Cardiac ablation
Clinical narrative: Afib flare requiring cardiac ablation after booster covid vax.
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was  viable until 2/21/23 despite  beyond use date of 1/22/23
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arteriosclerosis, Blood glucose normal, Brain injury, Catheter directed thrombolysis, Cerebral thrombosis
Clinical narrative: ON THE MORNING OF 12-3-22, PATIENT AND I GOT UP, GOT READY, ATE BREAKFAST, AND WENT TO OUR GRANDDAUGHTER'S BASKETBALL GAME AT 12:00PM. WE ARRIVED EARLY, SO WE WAITED IN THE CAR FOR TEN MINUTES, THEN WE WENT INTO THE GYM. THE PREVIOUS GAME WAS STILL GOING ON, SO WE WATCHED THAT, THEN WE WENT TO OUR SEATS ON THE TOP ROW IN THE BLEACHERS. WE TALKED TO AN EX-NEIGHBOR FOR ABOUT FIVE MINUTES, THEN WE SAT DOWN. EVERYTHING WAS COMPLETELY AT THIS POINT. I WAS ON PATIENT'S LEFT SIDE, OUR DAUGHTER-IN-LAW WAS ON HER RIGHT SIDE, AND OUR SON WAS NEXT TO HER EVERYTHING WAS NORMAL TO THIS POINT. SHORTLY AFTER THE GAME STARTED PATEINT'S LEFT HAND GRABBED MY RIGHT LEG, AND I ASKED HER IF SHE NEEDED ANYTHING AND SHE SAID NO IN A SOFT VOICE. THEN OUR DAUGHTER-IN-LAW AND I BOTH SAW HER EYES STARTING TO CLOSE, AND WE BOTH SAID ARE YOU OK? SHE SAID YES. HER EYES THEN WENT COMPLETELY SHUT, AND WE AGAIN ASKED IF SHE WAS OK, BUT THERE WAS NO RESPONSE. TWO NURSES FROM THE SPECTATORS CAME OVER TO TEND TO PATIENT AND MY SON CALLED THE LIFE SQUAD AND OUR OTHER SON. I TOLD THE LIFE SQUAD SHE WAS A DIABETEC, AND THEY CHECKED HER BLOOD SUGAR, BUT IT WAS OK. AT ABOUT 12:30 PM, THE LIFE SQUAD RUSHED HER TO THE HOSPITAL. OUR OTHER SON ARRIVED, AND WE ALL WAITED IN THE WAITING ROOM FOR ABOUT AN HOUR. TWO DOCTORS THEN CAME DOWN AND SAID THE SITUATION WAS VERY BAD, AS A BLOOD CLOT WENT TO PATIENT'S BRAIN AND CAUSED A SEVERE STROKE. THEY TRIED TO DISSOLVE THE CLOT AND SUCK IT OUT BY RUNNING A WIRE UP TO PATIENT'S BRAIN, BUT THEY RAN INTO COMPLICATIONS. THE PASSAGE WAS TOO NARROW FOR THEM TO WORK IN, A BLOOD VESSEL BROKE, AND THERE WAS A CHOLESTEROL BUILD UP. THEY KEP HER OVERNIGHT AND RAN ANOTHER CT SCAN. THEY ALSO PUT A BREATHING TUBE IN HER. WHEN WE WENT IN THE NEXT MORNING 12/4/22, THEY SAID THE CT SCAN WAS WORSE, WITH TOO MUCH BRAIN DAMAGE, AND SHE WAS NOT COMING BACK. ONE DOCTOR SAID SHE WA COMOTOSE AT THE GYM WHEN SHE CLOSED HER EYES, THEY SAID WE COULD LET HER LIKE THAT OR TAKE THE BREATHING TUBE OUT AND LET HER PASS. WE OPTED TO TAKE THE BREATHING TUBE OUT, AND SHE PASSED WITHIN HOURS. OFFICIAL CAUSE OF DEATH-ACUTE ISCHEMIC STROKE NO SYMTOMS AT ALL - EVERYTHING WAS NORMAL. PATIENT'S FOUR EARLIER SHOTS MODERNA - THIS ONE WAS PFIZER
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Coma, Computerised tomogram head abnormal, Death, Endotracheal intubation, Ischaemic stroke
Clinical narrative: ON THE MORNING OF 12-3-22, PATIENT AND I GOT UP, GOT READY, ATE BREAKFAST, AND WENT TO OUR GRANDDAUGHTER'S BASKETBALL GAME AT 12:00PM. WE ARRIVED EARLY, SO WE WAITED IN THE CAR FOR TEN MINUTES, THEN WE WENT INTO THE GYM. THE PREVIOUS GAME WAS STILL GOING ON, SO WE WATCHED THAT, THEN WE WENT TO OUR SEATS ON THE TOP ROW IN THE BLEACHERS. WE TALKED TO AN EX-NEIGHBOR FOR ABOUT FIVE MINUTES, THEN WE SAT DOWN. EVERYTHING WAS COMPLETELY AT THIS POINT. I WAS ON PATIENT'S LEFT SIDE, OUR DAUGHTER-IN-LAW WAS ON HER RIGHT SIDE, AND OUR SON WAS NEXT TO HER EVERYTHING WAS NORMAL TO THIS POINT. SHORTLY AFTER THE GAME STARTED PATEINT'S LEFT HAND GRABBED MY RIGHT LEG, AND I ASKED HER IF SHE NEEDED ANYTHING AND SHE SAID NO IN A SOFT VOICE. THEN OUR DAUGHTER-IN-LAW AND I BOTH SAW HER EYES STARTING TO CLOSE, AND WE BOTH SAID ARE YOU OK? SHE SAID YES. HER EYES THEN WENT COMPLETELY SHUT, AND WE AGAIN ASKED IF SHE WAS OK, BUT THERE WAS NO RESPONSE. TWO NURSES FROM THE SPECTATORS CAME OVER TO TEND TO PATIENT AND MY SON CALLED THE LIFE SQUAD AND OUR OTHER SON. I TOLD THE LIFE SQUAD SHE WAS A DIABETEC, AND THEY CHECKED HER BLOOD SUGAR, BUT IT WAS OK. AT ABOUT 12:30 PM, THE LIFE SQUAD RUSHED HER TO THE HOSPITAL. OUR OTHER SON ARRIVED, AND WE ALL WAITED IN THE WAITING ROOM FOR ABOUT AN HOUR. TWO DOCTORS THEN CAME DOWN AND SAID THE SITUATION WAS VERY BAD, AS A BLOOD CLOT WENT TO PATIENT'S BRAIN AND CAUSED A SEVERE STROKE. THEY TRIED TO DISSOLVE THE CLOT AND SUCK IT OUT BY RUNNING A WIRE UP TO PATIENT'S BRAIN, BUT THEY RAN INTO COMPLICATIONS. THE PASSAGE WAS TOO NARROW FOR THEM TO WORK IN, A BLOOD VESSEL BROKE, AND THERE WAS A CHOLESTEROL BUILD UP. THEY KEP HER OVERNIGHT AND RAN ANOTHER CT SCAN. THEY ALSO PUT A BREATHING TUBE IN HER. WHEN WE WENT IN THE NEXT MORNING 12/4/22, THEY SAID THE CT SCAN WAS WORSE, WITH TOO MUCH BRAIN DAMAGE, AND SHE WAS NOT COMING BACK. ONE DOCTOR SAID SHE WA COMOTOSE AT THE GYM WHEN SHE CLOSED HER EYES, THEY SAID WE COULD LET HER LIKE THAT OR TAKE THE BREATHING TUBE OUT AND LET HER PASS. WE OPTED TO TAKE THE BREATHING TUBE OUT, AND SHE PASSED WITHIN HOURS. OFFICIAL CAUSE OF DEATH-ACUTE ISCHEMIC STROKE NO SYMTOMS AT ALL - EVERYTHING WAS NORMAL. PATIENT'S FOUR EARLIER SHOTS MODERNA - THIS ONE WAS PFIZER
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unresponsive to stimuli, Vascular procedure complication, Vascular rupture, Vascular stenosis
Clinical narrative: ON THE MORNING OF 12-3-22, PATIENT AND I GOT UP, GOT READY, ATE BREAKFAST, AND WENT TO OUR GRANDDAUGHTER'S BASKETBALL GAME AT 12:00PM. WE ARRIVED EARLY, SO WE WAITED IN THE CAR FOR TEN MINUTES, THEN WE WENT INTO THE GYM. THE PREVIOUS GAME WAS STILL GOING ON, SO WE WATCHED THAT, THEN WE WENT TO OUR SEATS ON THE TOP ROW IN THE BLEACHERS. WE TALKED TO AN EX-NEIGHBOR FOR ABOUT FIVE MINUTES, THEN WE SAT DOWN. EVERYTHING WAS COMPLETELY AT THIS POINT. I WAS ON PATIENT'S LEFT SIDE, OUR DAUGHTER-IN-LAW WAS ON HER RIGHT SIDE, AND OUR SON WAS NEXT TO HER EVERYTHING WAS NORMAL TO THIS POINT. SHORTLY AFTER THE GAME STARTED PATEINT'S LEFT HAND GRABBED MY RIGHT LEG, AND I ASKED HER IF SHE NEEDED ANYTHING AND SHE SAID NO IN A SOFT VOICE. THEN OUR DAUGHTER-IN-LAW AND I BOTH SAW HER EYES STARTING TO CLOSE, AND WE BOTH SAID ARE YOU OK? SHE SAID YES. HER EYES THEN WENT COMPLETELY SHUT, AND WE AGAIN ASKED IF SHE WAS OK, BUT THERE WAS NO RESPONSE. TWO NURSES FROM THE SPECTATORS CAME OVER TO TEND TO PATIENT AND MY SON CALLED THE LIFE SQUAD AND OUR OTHER SON. I TOLD THE LIFE SQUAD SHE WAS A DIABETEC, AND THEY CHECKED HER BLOOD SUGAR, BUT IT WAS OK. AT ABOUT 12:30 PM, THE LIFE SQUAD RUSHED HER TO THE HOSPITAL. OUR OTHER SON ARRIVED, AND WE ALL WAITED IN THE WAITING ROOM FOR ABOUT AN HOUR. TWO DOCTORS THEN CAME DOWN AND SAID THE SITUATION WAS VERY BAD, AS A BLOOD CLOT WENT TO PATIENT'S BRAIN AND CAUSED A SEVERE STROKE. THEY TRIED TO DISSOLVE THE CLOT AND SUCK IT OUT BY RUNNING A WIRE UP TO PATIENT'S BRAIN, BUT THEY RAN INTO COMPLICATIONS. THE PASSAGE WAS TOO NARROW FOR THEM TO WORK IN, A BLOOD VESSEL BROKE, AND THERE WAS A CHOLESTEROL BUILD UP. THEY KEP HER OVERNIGHT AND RAN ANOTHER CT SCAN. THEY ALSO PUT A BREATHING TUBE IN HER. WHEN WE WENT IN THE NEXT MORNING 12/4/22, THEY SAID THE CT SCAN WAS WORSE, WITH TOO MUCH BRAIN DAMAGE, AND SHE WAS NOT COMING BACK. ONE DOCTOR SAID SHE WA COMOTOSE AT THE GYM WHEN SHE CLOSED HER EYES, THEY SAID WE COULD LET HER LIKE THAT OR TAKE THE BREATHING TUBE OUT AND LET HER PASS. WE OPTED TO TAKE THE BREATHING TUBE OUT, AND SHE PASSED WITHIN HOURS. OFFICIAL CAUSE OF DEATH-ACUTE ISCHEMIC STROKE NO SYMTOMS AT ALL - EVERYTHING WAS NORMAL. PATIENT'S FOUR EARLIER SHOTS MODERNA - THIS ONE WAS PFIZER
Age: 1.25
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna  confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 1.25
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Age: 1.5
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite of beyond use date of 1/22/23.
Age: 71.0
Sex: F
Vaccine: MMR
Symptoms: Extra dose administered, No adverse event
Clinical narrative: *No adverse event or reaction occurred*  Extra dose was given Pt was inadvertently given a 3rd dose 1 week 6/14/2022 after the 2nd dose was given 6/7/2022 Miscommunication among staff members  Pt has had no complaints or problems.
Age: 2.42
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23